疏血通与依达拉奉治疗进展性脑梗死疗效观察.docVIP

疏血通与依达拉奉治疗进展性脑梗死疗效观察 　　【摘要】 目的 评价疏血通与依达拉奉治疗进展性脑梗死的有效性和安全性。方法 60例进展性脑梗死患者随机分为治疗组和对照组，每组各30例。对照组用常规治疗方法舒血宁、复方丹参和营养脑细胞药物,治疗组用疏血通与依达拉奉和营养脑细胞药物。疗程均为14 d。结果 治疗组总有效率为86.7%，明显高于对照组70%，(P0.05),治疗为14 d，治疗组神经功能缺损程度评分明显改善，治疗组出现1例肾功能轻度异常，1例肝功能轻度异常均无给予处理，一周后正常，显示良好的安全性。结论 疏血通加用依达拉奉治疗进展性脑梗死效果显著，有效安全值得临床推广。? 　　【关键词】 　　疏血通；依达拉奉；进展性脑梗死；疗效 　　?? 　　A research on the efficacy of treating progressive cerebral infarction with Shuxuetong and Edaravone 　　 　　ZHAO Rui?bin, XU Shi?ping, YAN Li, et al.Tiankang Hospital of Tianchang city, Tianchang 239300,China 　　? 　　【Abstract】 Objective 　　This paper aims to evaluate the efficacy and safety of treating cerebral infarction with Shuxuetong and Edaravone. Methods 60 cases of progressive cerebral infarction were divided randomly into treatment group and the control group (30 cases in each). Treat the control group with Shuxuening Danshen drugs and nutrition of brain cells conventionally. Treat the treatment group with Shuxuetong and Edaravone drugs and nutrition of brain cells. The course of treatment lasts for 14 days.Results The total effective rate of treatment group was 86.7%, which was significantly higher than that of control group with a effective rate of 70%, (P0.05). The course of treatment lasts for 14 days. The neurological deficit scores of treatment group improved significantly. There were one case of mild renal function abnormalities and one case of mild abnormal liver function in the treatment group. Both were normal with good security indication without giving particular treatment in a week. Conclusion The efficacy of treating progressive cerebral infarction with Shuxuetong and Edaravone is excellent and safe. This method is worthy of clinical application widely.? 　　【Key words】 　　Shuxuetong;Edaravone;Progressive cerebral infarction;Effect 　　? 　　作者单位：239300安徽省天长市天康医院(赵瑞斌 徐士平 严丽 郭松翔);南京医科大学第二附属医院(吴祖舜) 　　 　　进展性脑梗死是指发生在起病6 h后，因脑梗死缺血的进展或组织坏死加重而出现神经功能恶化的一类脑梗死，病情进展一般发生在发病后6 h~1周［1］。它是由多种原因，多种机制共同参与的复杂状态，目前进展性脑梗死的发生，预后存在难以预知性